<DOC>
	<DOCNO>NCT00000549</DOCNO>
	<brief_summary>To determine estrogen replacement therapy , without low dose progesterone , slow progression induces regression coronary atherosclerosis postmenopausal woman .</brief_summary>
	<brief_title>Estrogen Replacement Atherosclerosis ( ERA ) Older Women</brief_title>
	<detailed_description>BACKGROUND : Cardiovascular disease number one cause death postmenopausal woman . Postmenopausal estrogen replacement associate low incidence cardiovascular disease woman , especially establish coronary artery disease . The strength apparent effect estrogen epidemiologic study suggest estrogen play fundamental role maintenance vascular health . Animal data suggest current practice add low dose progesterone prevent endometrial hyperplasia may inhibit beneficial effect estrogen coronary artery . Before commit million postmenopausal woman long-term estrogen use prevention coronary artery disease , mandatory demonstrate indeed protect coronary atherosclerosis , determine impact co-treatment progestin , understand mechanism estrogen may exert 's cardioprotective effect . The Office Research Women 's Health provide $ 500,000 Fiscal Year 1995 recruitment subject . DESIGN NARRATIVE : Randomized , placebo-controlled , blind . The minimum diameter coronary stenotic lesion measure angiography three year group receive unopposed estrogen replacement therapy , group receive estrogen replacement plus continuous low dose progestin , group receive placebo . The incidence clinical event document three group . Secondary objective trial include examine effect chronic acute estrogen administration endothelium-dependent coronary vasodilator capacity , plasma lipid lipoprotein , antioxidant activity , blood pressure , glucose metabolism , plasma hemostatic factor , well behavior , physical attribute , psychosocial parameter . There four pre-randomization variable order pre-stratify . These include current smoking status , insulin dependent diabetes , current lipid-lowering therapy , hospital angiogram perform . The study completion date list record obtain `` End Date '' enter Protocol Registration Results System ( PRS ) record .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Arteriosclerosis</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<mesh_term>Progestins</mesh_term>
	<criteria>Postmenopausal woman establish coronary atherosclerosis .</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2005</verification_date>
</DOC>